Early Onset Alzheimer Disease
10
1
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
80.0%
-6.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
A Study Testing Whether Low-Dose Radiation Could Help the Immune System and Possibly Improve Early-Onset Alzheimer's Disease.
48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease
Gene Therapy for APOE4 Homozygote of Alzheimer's Disease
A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease
Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain
RHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia
Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)